Article

proCardio podcast series

proCardio key visual with blue heart
Podcast series on the newest advancements in the management of cardiometabolic diseases

Welcome to the proCardio podcast series by Roche, offering an exploration of advancements in the prevention, screening, diagnosis, and implementation strategies for cardiometabolic disease management. 

Featuring interviews with leading cardiologists, the series covers critical topics including insights on cardiac biomarkers' use from real-world evidence, translating heart failure guidelines into practice, enabling early diagnosis, and discussing innovative trials. 

Join the host Konstantin Schmidt, SciComms Manager at Roche Diagnostics, as he engages with the brightest minds in the field to bring you 7 episodes, packed with expert insights and practical knowledge to help enhance clinical care for cardiometabolic diseases.

Sign up for CarDiaLogue

Prevention and Screening

Real world evidence and opportunities for early intervention in heart failure

Real world evidence and opportunities for early intervention in heart failure for people living with diabetes

Interview with Dr. Safia Chatur on the importance of real world evidence and what it tells us about the use of biomarkers (such as natriuretic peptides) in clinical routine for heart failure identification in people living with diabetes.

Implementation of NT-proBNP based screening for heart failure prevention in people with diabetes

Implementation of NT-proBNP based screening for heart failure prevention in people with diabetes

Interview with Prof. Rodica Pop-Busui on her extensive experience in implementing a heart failure screening program in a university network, translating guideline recommendation into clinical care.

Value of Troponins in Predicting Cardiovascular Disease Risk in the General Population

Value of Troponins in Predicting Cardiovascular Disease Risk in the General Population

Interview with Dr. Raphael Twerenbold on cardiometabolic risk assessment in the general population. Current standard of care and its limitations are explored along with the advantages of incorporating biomarkers in existing protocols.

Diagnostics and Implementation

Coming soon...

CarDiaLogue unites the passion for cardiology and diagnostics in an engaging dialogue

Join the #CarDiaLogue today and sign up for updates.

CarDiaLogue brings you the latest insights and valuable perspectives from some of the sharpest minds in cardiology to complement your specialist skills.

Other CarDiaLogue Articles

...
    ...